True Cell Type,Predicted Main Cell Type,Predicted Sub Cell Types,Possible Mixed Cell Types,Marker Number,Marker List,Iterations,Model,Provider,Tissue,Species,Additional Info,Conversation History
"cd8-positive, alpha-beta t cell",Cytotoxic Lymphocytes,"Activated/Effector NK Cells or NK-like T cells, Cytotoxic CD8+ T Cells (CTLs), potentially with an NK-like phenotype, Gamma-Delta T Cells (γδ T cells), particularly cytotoxic subsets",Activated Cytotoxic Lymphocytes with an NK-like and/or Gamma-Delta T Cell Phenotype,50,"KLRC2, XCL2, LINC02446, CRTAM, KLRK1, KLRC4, KLRD1, XCL1, GZMH, CD160, CD8B, NKG7, GZMA, GZMB, GZMK, CD8A, TRGC2, SLA2, TIGIT, TNFRSF9, GPR18, CCL4, PRF1, ATP8B4, APBA2, CCL4L2, DUSP4, CTSW, TMIGD2, TRGC1, CCL5, ABI3, IL21R, IFNG, CD7, CLIC3, ENTPD1, LDLRAD4, PTPN22, HOPX, GZMM, CST7, PARD6G, ZEB2, SH2D1A, LAYN, LAG3, PRKCH, AOAH, IKZF2",1,google/gemini-2.5-flash,openrouter,large intestine,human,N/A,"Final Annotation Agent: Here's a detailed analysis to identify the cell type based on the provided marker list: **Step 1. List the Key Functional Markers:** This list is rich in genes associated with cytotoxic function and immune activation. * **Cytotoxicity/Granzyme-related:** * **GZMH, GZMA, GZMB, GZMK, GZMM:** These are Granzymes, serine proteases crucial for inducing apoptosis in target cells. Their presence strongly indicates cytotoxic activity. GZMH and GZMB are particularly characteristic of NK cells and cytotoxic T lymphocytes (CTLs). * **PRF1 (Perforin 1):** A pore-forming protein essential for delivering granzymes into target cells, a hallmark of cytotoxic lymphocytes. * **NKG7:** A transmembrane protein found in the granules of cytotoxic lymphocytes, involved in granule exocytosis. * **CTSW (Cathepsin W):** A lysosomal cysteine protease expressed in NK cells and T cells, potentially involved in granule maturation or processing. * **Chemokines/Cytokines and Receptors:** * **XCL2, XCL1:** Lymphotactin (XCL1/2) are C-motif chemokines primarily produced by NK cells and CD8+ T cells, attracting other immune cells. * **CCL4, CCL4L2, CCL5:** Chemokines (MIP-1β, RANTES) involved in recruiting various immune cells, including T cells, NK cells, and monocytes, to sites of inflammation. * **IFNG (Interferon-gamma):** A potent pro-inflammatory cytokine produced by NK cells and T cells, crucial for antiviral and anti-tumor immunity. * **IL21R:** Receptor for Interleukin-21, a cytokine that promotes the differentiation and function of cytotoxic T cells and NK cells. * **TNFRSF9 (CD137/4-1BB):** A co-stimulatory receptor expressed on activated T cells and NK cells, enhancing their survival and effector functions. * **Immune Checkpoints/Regulatory Molecules:** * **TIGIT (T cell immunoreceptor with Ig and ITIM domains):** An inhibitory receptor expressed on NK cells and T cells, modulating their activation. * **LAG3 (Lymphocyte-activation gene 3):** An inhibitory receptor expressed on activated T cells and NK cells, contributing to immune exhaustion. * **Signaling/Adaptor Molecules:** * **ABI3:** An adaptor protein involved in actin cytoskeleton organization and immune cell signaling. * **SH2D1A (SAP):** An adaptor protein critical for NK cell and T cell signaling, particularly in NK-T cell interactions and cytotoxic function. * **PTPN22:** A lymphoid-specific phosphatase involved in regulating T cell activation. **Step 2. List the Key Cell Type Markers:** This list strongly points towards lymphocytes, specifically cytotoxic subsets. * **Natural Killer (NK) Cell Markers:** * **KLRC2 (NKG2C), KLRK1 (NKG2D), KLRC4 (NKG2D ligand), KLRD1 (CD94):** These are members of the C-type lectin-like receptor family, characteristic of NK cells. NKG2C and NKG2D are activating receptors, while CD94 forms a complex with NKG2A (not listed but often co-expressed) which is inhibitory. The presence of multiple KLRs is a strong indicator of NK cells. * **CD160:** A receptor expressed on NK cells and cytotoxic T cells, involved in cytotoxicity. * **CRTAM (Class I-restricted T cell-associated molecule):** Expressed on activated NK cells and CD8+ T cells, involved in cell-cell adhesion and cytokine production. * **T Cell Markers (especially Cytotoxic T Lymphocytes - CTLs):** * **CD8B, CD8A:** Components of the CD8 co-receptor, defining cytotoxic T lymphocytes (CTLs). * **TRGC2, TRGC1:** Components of the T cell receptor gamma chain, indicating gamma-delta T cells. * **CD7:** A pan-T cell marker, also found on some NK cells. * **Shared Lymphocyte Markers:** * **GPR18:** A G protein-coupled receptor expressed on various immune cells, including lymphocytes. * **ENTPD1 (CD39):** An ectonucleotidase expressed on regulatory T cells and some activated T cells and NK cells, involved in ATP hydrolysis. * **TMIGD2 (CD28H):** A co-stimulatory molecule expressed on T cells and NK cells. * **IKZF2 (Helios):** A transcription factor primarily associated with regulatory T cells, but also found in some activated effector T cells and NK cells. Its presence here might suggest a regulatory or exhausted phenotype within the cytotoxic population. **Step 3. Cross-reference Known Databases:** A quick search in scRNA-seq databases (e.g., Human Cell Atlas, PanglaoDB, CellMarker) for these markers consistently points towards: * **NK cells:** High expression of `KLRC2, KLRK1, KLRC4, KLRD1, XCL1, XCL2, GZMH, GZMB, PRF1, NKG7, CD160, CRTAM`. * **Cytotoxic T cells (CD8+ T cells):** High expression of `CD8A, CD8B, GZMA, GZMB, GZMK, PRF1, NKG7, IFNG, CCL5, TIGIT, LAG3, TNFRSF9`. * **Gamma-delta T cells:** Presence of `TRGC1, TRGC2` alongside cytotoxic markers. The co-expression of NK-specific C-type lectin receptors (KLRs) with CD8 and a strong cytotoxic gene signature is particularly informative. **Step 4. Determine the Most Probable General Cell Type:** Based on the overwhelming presence of cytotoxic effector molecules (granzymes, perforin, NKG7), chemokines (XCL1/2, CCL4/5), and specific receptor families (KLRs, CD8), the most probable general cell type is **Cytotoxic Lymphocytes**. **Step 5. Identify the Top 3 Most Probable Sub Cell Types:** 1. **Most Likely: Activated/Effector NK Cells or NK-like T cells (e.g., NKT cells, MAIT cells, or a hybrid cytotoxic lymphocyte population):** * **Reasoning:** The presence of multiple NK-specific C-type lectin receptors (KLRC2, KLRK1, KLRC4, KLRD1) is a very strong indicator of NK cell lineage. However, the co-expression of CD8A/B and TRGC1/2 (gamma-delta TCR) alongside these NK markers suggests a more complex cytotoxic lymphocyte population. This could represent a subset of NK cells with some T cell-like features, or a specialized cytotoxic T cell subset that expresses NK receptors (e.g., NKT cells, MAIT cells, or even a highly activated CD8+ T cell population that upregulates some NK markers). The strong cytotoxic machinery (GZMs, PRF1, NKG7) and chemokines (XCL1/2) are characteristic of highly active effector cells. The presence of TIGIT and LAG3 might suggest an activated or even slightly exhausted state, common in chronic inflammation or tumor microenvironments. * **Specific Markers:** KLRC2, XCL2, KLRK1, KLRC4, KLRD1, XCL1, GZMH, CD160, NKG7, GZMA, GZMB, GZMK, PRF1, CCL4, CCL5, IFNG, CRTAM. The co-expression of CD8A/B and TRGC1/2 with these NK markers is key here. 2. **Second Most Likely: Cytotoxic CD8+ T Cells (CTLs), potentially with an NK-like phenotype:** * **Reasoning:** The clear presence of CD8A and CD8B, along with a robust cytotoxic gene signature (GZMs, PRF1, NKG7, IFNG), strongly supports a CD8+ T cell identity. Many activated CD8+ T cells can upregulate some NK cell-associated receptors (e.g., KLRK1/NKG2D) and produce similar chemokines and cytokines. The presence of TIGIT and LAG3 is also common in activated or exhausted CTLs. The gamma-delta TCR components (TRGC1/2) suggest a subset of CD8+ gamma-delta T cells, which are known for their potent cytotoxic capabilities and can share features with NK cells. * **Specific Markers:** CD8B, NKG7, GZMA, GZMB, GZMK, CD8A, TRGC2, TIGIT, TNFRSF9, PRF1, CCL4, CCL5, IFNG, LAG3. The co-expression of KLRs would indicate an NK-like subset. 3. **Third Most Likely: Gamma-Delta T Cells (γδ T cells), particularly cytotoxic subsets:** * **Reasoning:** The explicit presence of TRGC2 and TRGC1 is a definitive marker for gamma-delta T cells. Many subsets of gamma-delta T cells, especially those found in mucosal tissues like the large intestine, are highly cytotoxic and can express NK cell receptors (like NKG2D/KLRK1) and produce granzymes and perforin. They play crucial roles in immune surveillance and host defense. Their cytotoxic profile aligns well with the other markers. * **Specific Markers:** TRGC2, TRGC1, GZMH, GZMA, GZMB, GZMK, PRF1, NKG7, IFNG, CCL5, KLRK1 (often expressed by γδ T cells). **Most Likely Subtype:** Considering the prominent and diverse array of NK-specific C-type lectin receptors (KLRC2, KLRK1, KLRC4, KLRD1) alongside the strong cytotoxic machinery and the presence of CD8A/B and TRGC1/2, the most likely subtype is **Activated Cytotoxic Lymphocytes with an NK-like and/or Gamma-Delta T Cell Phenotype**. This suggests a highly specialized and potent effector population, potentially a hybrid or a spectrum of cells that share features of both NK cells and cytotoxic T cells, which are increasingly recognized in mucosal immunity. Given the large intestine context, these cells would be critical for local immune defense. **Step 6. Provide a Concise Summary of Your Analysis:** This cell cluster exhibits a robust and diverse expression profile characteristic of **highly activated cytotoxic lymphocytes**. The presence of multiple NK-specific C-type lectin receptors (KLRC2, KLRK1, KLRC4, KLRD1) strongly points towards an NK cell component. Concurrently, the expression of CD8A/B and T cell receptor gamma chains (TRGC1/2) indicates a significant T cell contribution, specifically cytotoxic CD8+ T cells and/or gamma-delta T cells. The entire cluster is defined by a powerful cytotoxic effector signature, including numerous granzymes (GZMH, GZMA, GZMB, GZMK, GZMM), perforin (PRF1), and NKG7, along with key chemokines (XCL1/2, CCL4/5) and the cytokine IFNG. Immune checkpoint molecules like TIGIT and LAG3 suggest an activated or potentially exhausted state. Therefore, the most probable general cell type is **Cytotoxic Lymphocytes**. The top three most probable sub-cell types are: 1) Activated/Effector NK Cells or NK-like T cells (most likely), 2) Cytotoxic CD8+ T Cells (CTLs) with an NK-like phenotype, and 3) Cytotoxic Gamma-Delta T Cells. The most likely specific subtype is **Activated Cytotoxic Lymphocytes exhibiting a hybrid NK-like and/or Gamma-Delta T Cell phenotype**, reflecting a specialized effector population crucial for mucosal immunity in the large intestine. FINAL ANNOTATION COMPLETED | Coupling Validator: Validation result: VALIDATION PASSED | Formatting Agent: ```json { ""main_cell_type"": ""Cytotoxic Lymphocytes"", ""sub_cell_types"": [ ""Activated/Effector NK Cells or NK-like T cells"", ""Cytotoxic CD8+ T Cells (CTLs), potentially with an NK-like phenotype"", ""Gamma-Delta T Cells (γδ T cells), particularly cytotoxic subsets"" ], ""possible_mixed_cell_types"": [ ""Activated Cytotoxic Lymphocytes with an NK-like and/or Gamma-Delta T Cell Phenotype"" ] } ```"
intestinal crypt stem cell,Intestinal Stem Cells,"LGR5+ Crypt Base Columnar (CBC) Stem Cells, Early Progenitor Cells / Transit-Amplifying (TA) Cells, Quiescent/Reserve Stem Cells",,50,"AL031284.1, AC012085.1, IGFBPL1, HMGN2P6, CHCHD2P9, PPIAP40, LGR5, RPL7P54, AC010132.3, EIF5AP4, AC008694.2, COX5AP2, TDGF1, ASCL2, AC092670.1, NPM1P6, PPIAP11, AC090498.1, RPL41P1, CYCSP55, HMGN2P4, TPI1P1, RPL41P5, AL162151.2, PPIAP29, HNRNPA1P4, AC016596.2, AL603825.1, RPL9P21, AC005884.2, PPIAP31, HMGN1P36, HMGN2P41, AL035411.1, RPS26P39, FABP5P7, SDHDP6, ATP5PFP1, EEF1A1P5, RPSAP8, HMGN2P3, SLC39A2, KRT8P13, RPL21P16, RPSAP15, HMGN1P38, AF279873.1, RPL7P6, AC112491.1, AC022968.1",1,google/gemini-2.5-flash,openrouter,large intestine,human,N/A,"Final Annotation Agent: Here's a step-by-step analysis to identify the cell type based on the provided marker list: **Step 1. List the Key Functional Markers:** Upon initial review, many of the listed genes are pseudogenes (indicated by 'P' or 'PS' in their names, or by their genomic locus identifiers like ACxxxxxx.x, ALxxxxxx.x, AFxxxxxx.x) or uncharacterized loci. These are generally not considered functional markers for cell type identification in the same way protein-coding genes are. However, some protein-coding genes are present. * **LGR5 (Leucine-rich repeat-containing G protein-coupled receptor 5):** This is a well-established and highly significant marker for intestinal stem cells. LGR5 is a Wnt target gene and is expressed at the very bottom of the intestinal crypts, marking actively cycling, multipotent stem cells responsible for regenerating the entire intestinal epithelium. * **ASCL2 (Achaete-scute homolog 2):** Another critical transcription factor involved in intestinal stem cell maintenance and proliferation. ASCL2 is a direct target of Wnt signaling and works in conjunction with LGR5 to specify and maintain the stem cell phenotype. * **TDGF1 (Teratocarcinoma-derived growth factor 1, also known as Cripto):** While not exclusively a stem cell marker, TDGF1 is involved in embryonic development and stem cell maintenance, often acting as a co-receptor for TGF-beta and Nodal signaling pathways. Its presence can support a stem/progenitor cell identity. * **IGFBPL1 (Insulin-like growth factor binding protein-like 1):** While less specific than LGR5 or ASCL2, IGFBPL1 has been implicated in cell growth and differentiation, and its expression can sometimes be associated with progenitor populations. * **SLC39A2 (Solute Carrier Family 39 Member 2, also known as ZIP2):** This gene encodes a zinc transporter. While zinc transporters have diverse roles, some are involved in cell proliferation and differentiation, and their specific expression patterns can sometimes be informative. However, it's not a primary stem cell marker. **Step 2. List the Key Cell Type Markers:** Given the tissue context (large intestine) and the prominent functional markers, we are looking for markers indicative of intestinal epithelial cells, specifically those with stem/progenitor characteristics. * **LGR5:** As mentioned above, this is the canonical marker for actively cycling intestinal stem cells located at the crypt base. * **ASCL2:** Reinforces the stem cell identity, working alongside LGR5. Many of the other listed genes are pseudogenes (e.g., HMGN2P6, CHCHD2P9, PPIAP40, RPL7P54, EIF5AP4, COX5AP2, NPM1P6, PPIAP11, RPL41P1, CYCSP55, HMGN2P4, TPI1P1, RPL41P5, PPIAP29, HNRNPA1P4, RPL9P21, PPIAP31, HMGN1P36, HMGN2P41, RPS26P39, FABP5P7, SDHDP6, ATP5PFP1, EEF1A1P5, RPSAP8, HMGN2P3, KRT8P13, RPL21P16, RPSAP15, HMGN1P38, RPL7P6) or uncharacterized genomic loci (e.g., AL031284.1, AC012085.1, AC010132.3, AC008694.2, AC092670.1, AC090498.1, AL162151.2, AC016596.2, AL603825.1, AC005884.2, AL035411.1, AF279873.1, AC112491.1, AC022968.1). These are generally not used for specific cell type annotation as they do not encode functional proteins or their function is unknown. Their presence in a highly expressed list might indicate high transcriptional activity in general, or perhaps some regulatory roles, but they don't directly point to a specific cell type. The focus must remain on the protein-coding genes with known functions. **Step 3. Cross-reference Known Databases:** * **LGR5:** Widely recognized in scRNA-seq databases and literature as *the* marker for intestinal stem cells. Searching for ""LGR5 intestinal stem cell"" yields countless results. * **ASCL2:** Similarly, ""ASCL2 intestinal stem cell"" confirms its role in maintaining the stem cell niche. * **TDGF1:** While not as exclusive, its association with stemness and early development is documented. Databases like Human Protein Atlas, GeneCards, and various scRNA-seq atlases (e.g., Tabula Sapiens, Human Cell Atlas) consistently show high expression of LGR5 and ASCL2 in intestinal crypt base columnar (CBC) cells, which are the primary intestinal stem cells. **Step 4. Determine the Most Probable General Cell Type:** The overwhelming presence and high expression of **LGR5** and **ASCL2** as the most prominent functional markers strongly indicate that this cluster represents **Intestinal Stem Cells**. These two genes are the defining features of the actively cycling, multipotent stem cells responsible for epithelial renewal in the large intestine (and small intestine). **Step 5. Identify the Top 3 Most Probable Sub Cell Types:** Given the strong stem cell signature, the sub-types would likely be variations or states within the stem cell compartment. 1. **LGR5+ Crypt Base Columnar (CBC) Stem Cells:** This is the most probable and direct annotation. LGR5 is the canonical marker for these actively cycling, multipotent stem cells located at the very bottom of the intestinal crypts. ASCL2 further supports this identity. These cells are responsible for generating all other epithelial cell types in the intestine. 2. **Early Progenitor Cells / Transit-Amplifying (TA) Cells (with residual stem cell features):** While LGR5 expression typically defines the *stem* cell, some early progenitor cells that have just exited the stem cell state might still retain some LGR5 expression, albeit at lower levels, or express other stem-associated genes as they begin to differentiate and proliferate rapidly. However, the high ranking of LGR5 suggests a more definitive stem cell state. 3. **Quiescent/Reserve Stem Cells (e.g., Bmi1+ or Hopx+ cells, if LGR5 is also co-expressed or if the population is heterogeneous):** In some contexts, there are also quiescent or ""reserve"" stem cells that can be activated upon injury. While LGR5+ cells are typically considered active, the stem cell niche is complex. However, without specific markers for quiescence (like Bmi1 or Hopx), and with LGR5 being so prominent, this is less likely to be the primary identity compared to active CBCs. **Most Likely Subtype:** Based on the strong and high-ranking expression of **LGR5** and **ASCL2**, the most likely subtype is **LGR5+ Crypt Base Columnar (CBC) Stem Cells**. **Step 6. Provide a Concise Summary of Your Analysis:** This cell cluster from the large intestine exhibits a highly specific gene expression profile dominated by canonical intestinal stem cell markers. The top functional markers, **LGR5** and **ASCL2**, are unequivocally associated with actively cycling, multipotent stem cells located at the crypt base in the intestinal epithelium. LGR5 is the definitive marker for these cells, responsible for the continuous renewal of the intestinal lining, while ASCL2 is a critical transcription factor maintaining their stemness. The presence of TDGF1 further supports a stem/progenitor identity. While many other genes in the list are pseudogenes or uncharacterized loci, the clear and strong signal from LGR5 and ASCL2 allows for a confident annotation. Therefore, this cluster is identified as **LGR5+ Crypt Base Columnar (CBC) Intestinal Stem Cells**. FINAL ANNOTATION COMPLETED | Coupling Validator: Validation result: VALIDATION PASSED | Formatting Agent: ```json { ""main_cell_type"": ""Intestinal Stem Cells"", ""sub_cell_types"": [""LGR5+ Crypt Base Columnar (CBC) Stem Cells"", ""Early Progenitor Cells / Transit-Amplifying (TA) Cells"", ""Quiescent/Reserve Stem Cells""], ""possible_mixed_cell_types"": [] } ```"
intestinal enteroendocrine cell,Enteroendocrine Cells,"L-cells, Enterochromaffin (EC) cells, S-cells",,50,"GCG, PCSK1, AC090679.1, UCN3, PYY, INSL5, CHGA, LCN15, SCG2, FEV, CPLX2, NKX2-2, AL133325.3, C1orf127, LINC01014, SCGN, SLC18A1, SCG3, SCG5, TPH1, MARCH4, INSM1, RTN1, CRYBA2, SNAP25, CHGB, CRMP1, KCNB2, RFX6, AMER3, SLC32A1, CDK5R2, AVPR1B, VWA5B2, AC022893.2, ABCC8, RIMBP2, AL161658.1, COL2A1, CELF3, SCT, RIIAD1, SSTR5-AS1, RGS4, ARX, PRPH, INA, F5, AP003062.3, SLC5A8",1,google/gemini-2.5-flash,openrouter,large intestine,human,N/A,"Final Annotation Agent: Here's a step-by-step analysis to identify the cell type based on the provided marker list: **Step 1. List the Key Functional Markers:** This list is rich in genes associated with neuroendocrine function, hormone production, and neuronal processes. * **Hormone Production and Secretion:** * **GCG (Glucagon):** A key hormone involved in glucose homeostasis. While typically associated with pancreatic alpha cells, enteroendocrine cells in the gut can also produce glucagon or glucagon-like peptides. * **PCSK1 (Proprotein Convertase Subtilisin/Kexin Type 1):** An enzyme crucial for the proteolytic processing of prohormones and proneuropeptides into their active forms. Essential for the maturation of many peptide hormones, including glucagon, insulin, and somatostatin. * **UCN3 (Urocortin 3):** A neuropeptide belonging to the corticotropin-releasing hormone family, involved in stress response and satiety. * **PYY (Peptide YY):** A gut hormone released in response to feeding, involved in satiety and gut motility regulation. * **INSL5 (Insulin-like peptide 5):** A relaxin-family peptide hormone, primarily expressed in enteroendocrine cells of the colon, implicated in gut motility and glucose metabolism. * **CHGA (Chromogranin A):** A general marker for neuroendocrine cells, involved in the packaging and secretion of peptide hormones and neurotransmitters. * **SCG2 (Secretogranin II), SCGN (Secretagogin), SCG3 (Secretogranin III), SCG5 (Secretogranin V/Neurosecretory protein VGF):** Members of the granin family, involved in the storage and release of peptide hormones and neurotransmitters in neuroendocrine cells. * **TPH1 (Tryptophan Hydroxylase 1):** The rate-limiting enzyme in serotonin synthesis, indicating serotonin-producing cells. * **SCT (Secretin):** A hormone that regulates water homeostasis throughout the body and influences the environment of the duodenum by regulating secretions in the stomach, pancreas, and liver. * **ABCC8 (ATP Binding Cassette Subfamily C Member 8):** Encodes SUR1, a subunit of the ATP-sensitive potassium channel, often found in cells that regulate hormone secretion in response to metabolic cues (e.g., pancreatic beta cells, but also relevant in some enteroendocrine cells). * **Neurotransmitter Synthesis, Release, and Neuronal Function:** * **CPLX2 (Complexin 2):** A synaptic protein involved in regulating neurotransmitter release. * **SLC18A1 (Solute Carrier Family 18 Member A1/VMAT1):** A vesicular monoamine transporter, responsible for packaging monoamine neurotransmitters (like serotonin) into vesicles. * **SNAP25 (Synaptosomal-Associated Protein, 25kDa):** A component of the SNARE complex, essential for synaptic vesicle fusion and neurotransmitter release. * **CHGB (Chromogranin B):** Another granin family member, similar to CHGA, indicating neuroendocrine differentiation. * **CRMP1 (Collapsin Response Mediator Protein 1):** Involved in neuronal development and axon guidance. * **KCNB2 (Potassium Voltage-Gated Channel Subfamily B Member 2):** A voltage-gated potassium channel, involved in regulating neuronal excitability. * **SLC32A1 (Solute Carrier Family 32 Member A1/VGAT):** A vesicular GABA transporter, indicating cells capable of packaging and releasing GABA. * **RIMBP2 (RIM Binding Protein 2):** Involved in synaptic vesicle release and active zone organization. * **PRPH (Peripherin):** An intermediate filament protein found in peripheral neurons and some neuroendocrine cells. * **INA (Internexin neuronal intermediate filament protein alpha):** Another neuronal intermediate filament protein. * **Transcription Factors and Developmental Regulators:** * **FEV (Fez family zinc finger 2):** A transcription factor involved in the development of specific neuronal and neuroendocrine cell types, including serotonin-producing neurons. * **NKX2-2 (NK2 Homeobox 2):** A homeodomain transcription factor crucial for the development of various neuroendocrine cell types, including pancreatic alpha and beta cells, and some enteroendocrine cells. * **INSM1 (Insulinoma-associated protein 1):** A key neuroendocrine differentiation factor, essential for the development of all neuroendocrine cells. * **RFX6 (Regulatory Factor X6):** A transcription factor critical for the development of pancreatic islet cells and some enteroendocrine cells. * **ARX (Aristaless Related Homeobox):** A transcription factor involved in the development of various tissues, including the pancreas and brain, and can be found in specific enteroendocrine cell subtypes. **Step 2. List the Key Cell Type Markers:** Based on the functional markers, the overwhelming evidence points towards a neuroendocrine cell type. * **General Neuroendocrine Markers:** * **CHGA, CHGB, SCG2, SCGN, SCG3, SCG5:** These are classic markers for neuroendocrine cells across various tissues. * **PCSK1:** Essential for processing neuroendocrine hormones. * **INSM1:** A pan-neuroendocrine differentiation factor. * **Enteroendocrine Cell Specificity (within the large intestine context):** * **PYY, INSL5:** These are strongly associated with enteroendocrine L-cells, particularly in the colon/large intestine. * **GCG:** While also pancreatic, its presence in the large intestine context often points to L-cells (producing GLP-1/2 and GCG, or related peptides). * **UCN3:** Can be found in specific enteroendocrine populations. * **TPH1, SLC18A1:** Indicate serotonin-producing enterochromaffin (EC) cells. * **SCT:** Secretin-producing S-cells. * **NKX2-2, RFX6, ARX:** Transcription factors known to regulate enteroendocrine cell development and subtype specification. * **Neuronal/Synaptic Markers (supporting neuroendocrine nature):** * **CPLX2, SNAP25, KCNB2, RIMBP2, PRPH, INA:** These genes, while typically neuronal, are also highly expressed in neuroendocrine cells due to their shared mechanisms of regulated secretion and excitability. * **Less Specific/Contextual Markers:** * **LCN15 (Lipocalin 15):** A less common marker, but some lipocalins have been implicated in gut function. Its specific role here is less clear without further context. * **RTN1 (Reticulon 1):** Involved in ER morphology and protein trafficking, can be expressed in various cell types, including neurons and neuroendocrine cells. * **CRYBA2 (Crystallin Beta A2):** Typically associated with the lens of the eye, its presence here is unusual and might indicate a less common or stress-induced expression, or a potential artifact/low specificity. * **CDK5R2 (Cyclin Dependent Kinase 5 Regulatory Subunit 2):** Involved in neuronal development and function. * **AVPR1B (Arginine Vasopressin Receptor 1B):** A G-protein coupled receptor, can be found in various tissues, including the brain and some endocrine cells. * **CELF3 (CUGBP Elav-like Family Member 3):** An RNA binding protein, involved in neuronal differentiation. * **RGS4 (Regulator Of G Protein Signaling 4):** Modulates G-protein coupled receptor signaling, expressed in many cell types. * **SLC5A8 (Solute Carrier Family 5 Member 8):** A sodium-coupled monocarboxylate transporter, involved in nutrient absorption, but also found in some enteroendocrine cells. **Step 3. Cross-reference Known Databases:** A quick search in databases like the Human Protein Atlas, Allen Brain Atlas, and scRNA-seq atlases (e.g., Tabula Sapiens, Human Cell Atlas) for these markers in the context of the large intestine consistently points to **enteroendocrine cells**. * **PYY, INSL5, GCG, TPH1, SCT, CHGA, CHGB, PCSK1, INSM1, NKX2-2, RFX6** are all well-established markers for various enteroendocrine cell subtypes in the gut. * The co-expression of multiple granins (CHGA, SCG2, SCGN, SCG3, SCG5) and processing enzymes (PCSK1) strongly supports a neuroendocrine identity. * The presence of neuronal-like machinery (SNAP25, CPLX2, SLC18A1, SLC32A1) further reinforces the neurosecretory nature of these cells. **Step 4. Determine the Most Probable General Cell Type:** Based on the overwhelming presence of genes involved in hormone synthesis, processing, storage, and secretion, along with key neuroendocrine transcription factors and neuronal-like machinery, the most probable general cell type is **Enteroendocrine Cells**. **Step 5. Identify the Top 3 Most Probable Sub Cell Types:** Given the large intestine context and the specific markers, we can infer specific enteroendocrine subtypes. 1. **Most Likely: L-cells (PYY/GLP-1/GCG-producing cells)** * **Key Markers:** **PYY, INSL5, GCG, PCSK1, CHGA, CHGB, SCG2, SCG3, SCG5, NKX2-2, RFX6, ARX.** * **Reasoning:** The high expression of PYY and INSL5 is highly characteristic of L-cells, which are abundant in the large intestine. While GCG is also present, in the gut, L-cells produce proglucagon, which is differentially processed to yield GLP-1, GLP-2, and oxyntomodulin, rather than pancreatic glucagon. The presence of PCSK1 is critical for this processing. The transcription factors NKX2-2, RFX6, and ARX are known to be involved in L-cell development and function. 2. **Second Most Likely: Enterochromaffin (EC) cells (Serotonin-producing cells)** * **Key Markers:** **TPH1, SLC18A1, CHGA, CHGB, PCSK1, SNAP25, CPLX2, INSM1.** * **Reasoning:** TPH1 is the rate-limiting enzyme for serotonin synthesis, and SLC18A1 (VMAT1) packages serotonin into vesicles. EC cells are the most abundant enteroendocrine cell type in the gut and are crucial for gut motility and sensation. The general neuroendocrine markers also support this. 3. **Third Most Likely: S-cells (Secretin-producing cells) or other less abundant subtypes.** * **Key Markers:** **SCT, CHGA, CHGB, PCSK1, INSM1.** * **Reasoning:** The presence of SCT directly points to S-cells. While S-cells are more common in the duodenum, they can be found throughout the small and large intestine. The general neuroendocrine markers support this. The presence of UCN3 and ABCC8 might also hint at other less common enteroendocrine subtypes, but the evidence for L-cells and EC cells is stronger with the given markers. **Most Likely Subtype:** Based on the high ranking and specificity of **PYY** and **INSL5**, the most likely subtype is **L-cells**. The presence of GCG further supports the proglucagon-producing nature of these cells. **Step 6. Provide a Concise Summary of Your Analysis:** This cell cluster from the human large intestine is identified as **Enteroendocrine Cells**. The marker profile is dominated by genes involved in the synthesis, processing, storage, and secretion of peptide hormones and neurotransmitters, characteristic of neuroendocrine differentiation. Key markers such as **PYY, INSL5, GCG, PCSK1, CHGA, CHGB, TPH1, SLC18A1, SCT, INSM1, NKX2-2, and RFX6** strongly support this annotation. The co-expression of neuronal-like machinery (e.g., SNAP25, CPLX2) further reinforces their neurosecretory function. Among the enteroendocrine subtypes, the most probable identity is **L-cells**, given the prominent expression of **PYY** and **INSL5**, which are highly specific to this cell type in the large intestine, alongside proglucagon (GCG) processing machinery. Enterochromaffin (EC) cells and S-cells are also plausible but less likely as the primary identity based on the top-ranked markers. FINAL ANNOTATION COMPLETED | Coupling Validator: Validation result: VALIDATION PASSED | Formatting Agent: ```json { ""main_cell_type"": ""Enteroendocrine Cells"", ""sub_cell_types"": [""L-cells"", ""Enterochromaffin (EC) cells"", ""S-cells""], ""possible_mixed_cell_types"": [] } ```"
monocyte,Enteric Nervous System Cells,"Enteric Glial Cells, Enteric Neurons, Neural Crest Progenitors / Immature Enteric Cells","Enteric Glial Cells, Enteric Neurons",50,"NKAIN3, SPP1, CDH19, TSPAN11, PLP1, L1CAM, MYOT, IGSF11, NRXN1, SLC35F1, AL136298.1, SFRP5, Z97205.2, AL358216.1, SOX10, MEGF10, SYT10, CADM2, SLITRK2, SOX2, CRTAC1, CHL1, ZNF536, FOXD3, PTPRZ1, GRIK3, TUBB2B, CMTM5, LINC01436, TTYH1, ADARB2, CDH2, TENM3, WNT6, ATP1A2, NRXN3, KCNMB4, TMEM132B, LPL, GFRA2, CHADL, FLRT1, CHST9, GJC3, Z95114.1, RHAG, FOXD3-AS1, BMS1P10, FAM19A5, FGFBP2",1,google/gemini-2.5-flash,openrouter,large intestine,human,N/A,"Final Annotation Agent: Okay, I will perform a comprehensive single-cell RNA sequencing annotation for the provided marker list from a human large intestine tissue sample. **Step-by-Step Analysis:** **1. List the Key Functional Markers:** * **SPP1 (Secreted Phosphoprotein 1, Osteopontin):** Involved in cell adhesion, migration, and immune modulation. Often associated with macrophages, but also found in other cell types, including some epithelial and stromal cells, and can be upregulated in inflammatory conditions or cancer. * **PLP1 (Proteolipid Protein 1):** A major component of myelin in the central and peripheral nervous systems. Its presence in the large intestine is highly unusual for typical intestinal cells and strongly suggests a neural or glial origin. * **L1CAM (L1 Cell Adhesion Molecule):** A neuronal cell adhesion molecule involved in neuron migration, differentiation, and fasciculation. Also expressed in some epithelial cancers. Its co-expression with PLP1 further supports a neural lineage. * **MYOT (Myotilin):** Primarily known for its role in muscle Z-disc structure. Its presence here is less straightforward but could indicate a cell type with some contractile or cytoskeletal organization, or potentially a non-muscle cell expressing it ectopically. However, in the context of neural markers, it might be less relevant for primary cell type identification. * **NRXN1 (Neurexin 1), NRXN3 (Neurexin 3):** Presynaptic cell adhesion molecules crucial for synapse formation and function in the nervous system. Strong indicators of neuronal or neural-associated cells. * **SLC35F1 (Solute Carrier Family 35 Member F1):** A solute carrier, generally involved in transport. Its specific functional role in cell type identification is less direct without further context, but some SLCs are enriched in specific neural populations. * **SOX10 (SRY-Box Transcription Factor 10):** A master regulator transcription factor critical for neural crest development, including melanocytes, Schwann cells, and enteric glia. Its presence is a very strong indicator of neural crest-derived cells. * **MEGF10 (Multiple EGF-Like Domains 10):** A transmembrane protein involved in cell adhesion and phagocytosis, particularly in glial cells and macrophages. * **SYT10 (Synaptotagmin 10):** A synaptic vesicle protein involved in neurotransmitter release. Another strong indicator of neuronal or neuroendocrine cells. * **CADM2 (Cell Adhesion Molecule 2):** A neuronal cell adhesion molecule involved in synapse formation and maintenance. * **SLITRK2 (SLIT and NTRK-Like Family Member 2):** A transmembrane protein involved in neuronal development and synapse formation. * **SOX2 (SRY-Box Transcription Factor 2):** A transcription factor involved in maintaining pluripotency and stem cell identity, also expressed in neural stem cells and some mature neural populations. Its co-expression with SOX10 is significant. * **PTPRZ1 (Protein Tyrosine Phosphatase Receptor Type Z1):** A receptor-type protein tyrosine phosphatase expressed in the central nervous system, involved in neural development and glial differentiation. * **GRIK3 (Glutamate Ionotropic Receptor Kainate Type Subunit 3):** A subunit of kainate receptors, which are ionotropic glutamate receptors. Strongly indicative of neuronal cells. * **TUBB2B (Tubulin Beta 2B Class IIb):** A beta-tubulin isoform predominantly expressed in neurons, involved in microtubule formation. * **TTYH1 (Tweety Homolog 1):** A calcium-activated chloride channel, expressed in various tissues, including the nervous system. * **ADARB2 (Adenosine Deaminase RNA Specific B2):** Involved in RNA editing, particularly in the nervous system. * **CDH2 (Cadherin 2, N-Cadherin):** A cell adhesion molecule important in neural development and synapse formation. * **TENM3 (Teneurin Transmembrane Protein 3):** Involved in neuronal connectivity and axon guidance. * **ATP1A2 (ATPase Na+/K+ Transporting Subunit Alpha 2):** A subunit of the Na+/K+-ATPase, expressed in various tissues, but specific isoforms can be enriched in neurons or glia. * **KCNMB4 (Potassium Calcium-Activated Channel Subfamily M Beta Member 4):** A regulatory subunit of large conductance calcium-activated potassium channels, found in excitable cells like neurons. * **GFRA2 (GDNF Family Receptor Alpha 2):** A co-receptor for neurturin, involved in the development and survival of various neuronal populations. * **FLRT1 (Fibronectin Leucine Rich Transmembrane Protein 1):** Involved in cell adhesion and neuronal development. * **CHST9 (Carbohydrate Sulfotransferase 9):** Involved in sulfation of carbohydrates, less direct for cell type identification. * **GJC3 (Gap Junction Protein Gamma 3, Connexin-30.2):** A gap junction protein, can be found in various cell types, including some neural populations. * **FAM19A5 (Family With Sequence Similarity 19 Member A5):** A secreted protein, part of the TAFA family, some members of which are expressed in the nervous system and have neurotrophic functions. **2. List the Key Cell Type Markers:** The most striking feature of this marker list is the overwhelming presence of genes associated with the nervous system, particularly neurons and glial cells, and specifically those derived from the neural crest. * **Neural Crest/Glial Markers:** * **SOX10:** Definitive marker for neural crest derivatives, including Schwann cells and enteric glia. * **PLP1:** Major component of myelin, characteristic of oligodendrocytes (CNS) and Schwann cells (PNS). In the large intestine, this strongly points to Schwann cells or enteric glial cells. * **L1CAM:** Neuronal adhesion molecule, also expressed by Schwann cells. * **FOXD3:** Transcription factor involved in neural crest development and maintenance. * **PTPRZ1:** Expressed in glial cells and involved in neural development. * **MEGF10:** Expressed in glial cells. * **CHL1 (Cell Adhesion Molecule L1 Like):** A neuronal adhesion molecule, also expressed by glia. * **GFRA2:** Receptor for neurturin, important for enteric nervous system development. * **Neuronal Markers:** * **NRXN1, NRXN3:** Presynaptic adhesion molecules. * **SYT10:** Synaptic vesicle protein. * **CADM2, SLITRK2, TENM3, FLRT1:** Neuronal adhesion/development molecules. * **GRIK3:** Ionotropic glutamate receptor subunit. * **TUBB2B:** Neuron-specific tubulin. * **SOX2:** Neural stem cell/progenitor marker, also in some mature neurons. * **ADARB2:** RNA editing enzyme enriched in neurons. * **CDH2:** N-Cadherin, important for neuronal adhesion. * **ATP1A2, KCNMB4:** Ion channel/pump subunits found in excitable cells. * **Other Markers:** * **SPP1:** While often associated with macrophages, its co-expression with strong neural markers might indicate a specific functional state of neural cells or a minor contaminating population. However, given the strength of neural markers, it's more likely a context-dependent expression within the neural lineage (e.g., in response to injury or specific signaling). * **NKAIN3, TSPAN11, CDH19, SLC35F1, AL136298.1, SFRP5, Z97205.2, AL358216.1, ZNF536, CRTAC1, LINC01436, CMTM5, WNT6, CHADL, RHAG, FOXD3-AS1, BMS1P10, FGFBP2:** These are less specific or less well-characterized in the context of definitive cell type identification without further information. Some might be broadly expressed or represent minor functional roles. WNT6 and SFRP5 are involved in Wnt signaling, which is important in many developmental processes, including neural crest. **3. Cross-reference Known Databases:** Searching scRNA-seq databases (e.g., Human Cell Atlas, PanglaoDB, CellMarker, specific gut scRNA-seq studies) for these markers in the large intestine context consistently points towards cells of the enteric nervous system (ENS). * **SOX10, PLP1, L1CAM, NRXN1, PTPRZ1, GFRA2, FOXD3:** These are canonical markers for enteric glial cells and/or enteric neurons. * **SOX10 and PLP1 co-expression:** This combination is highly characteristic of Schwann cells and enteric glial cells, which are myelinating or myelin-like glia in the peripheral nervous system and gut, respectively. * **Neuronal markers (NRXN1, SYT10, GRIK3, TUBB2B):** These confirm the presence of neuronal components. In the large intestine, the nervous system components are primarily the enteric nervous system (ENS), which consists of neurons and glial cells. Enteric glial cells share many characteristics with Schwann cells and astrocytes. **4. Determine the Most Probable General Cell Type:** Based on the overwhelming and consistent expression of neural crest-derived markers (SOX10, FOXD3), myelin-associated protein (PLP1), and a plethora of neuronal and glial-specific adhesion molecules, synaptic proteins, and transcription factors, the most probable general cell type is **Enteric Nervous System Cells (Neurons and Glia)**. **5. Identify the Top 3 Most Probable Sub Cell Types:** Given the strong presence of both glial and neuronal markers, the cluster likely represents a mixed population or cells with characteristics of both. 1. **Enteric Glial Cells:** * **Rationale:** The presence of **SOX10** (master regulator for neural crest and glial development), **PLP1** (myelin protein, characteristic of Schwann cells/enteric glia), **L1CAM**, **PTPRZ1**, **MEGF10**, **GFRA2**, and **FOXD3** are all strong indicators of enteric glial cells. Enteric glia are crucial for ENS function, neuronal support, and gut homeostasis. The high expression of PLP1 is particularly compelling for a glial subtype, suggesting a myelinating or myelin-like glial cell. * **Supporting evidence:** Many studies characterize enteric glia by SOX10, GFAP, S100B, and sometimes PLP1. The presence of PLP1 is a strong differentiator for a specific glial subtype. 2. **Enteric Neurons:** * **Rationale:** The abundant expression of definitive neuronal markers such as **NRXN1, NRXN3, SYT10, GRIK3, TUBB2B, CADM2, SLITRK2, TENM3, CDH2, ATP1A2, KCNMB4**, and **ADARB2** strongly indicates the presence of enteric neurons. These markers cover presynaptic components, neurotransmitter receptors, cytoskeletal elements, and ion channels critical for neuronal function. * **Supporting evidence:** These are classic pan-neuronal markers, and their high expression points to a significant neuronal component within the cluster. 3. **Neural Crest Progenitors / Immature Enteric Cells:** * **Rationale:** The co-expression of **SOX10** (neural crest specifier) and **SOX2** (stemness/progenitor marker, also in neural stem cells) suggests that there might be a population of less differentiated cells or progenitors within the neural lineage. **FOXD3** also supports a neural crest origin. While many markers point to mature neurons and glia, the presence of these progenitor markers could indicate ongoing differentiation or a subpopulation with developmental plasticity. * **Supporting evidence:** The ENS is continuously remodeled, and progenitor populations exist. The combination of SOX10 and SOX2, while also found in mature cells, can indicate a less committed state. **Most Likely Subtype:** Based on the overall marker profile, particularly the very high expression of **PLP1** alongside **SOX10** and a broad range of neural adhesion and structural proteins, the most likely subtype is **Enteric Glial Cells**, specifically those with a Schwann cell-like or myelinating phenotype. The presence of numerous neuronal markers suggests either a close association with neurons (as glia support neurons) or a mixed cluster containing both glia and neurons, but the prominence of PLP1 and SOX10 leans heavily towards glia as the primary identity or a very dominant glial component. **6. Provide a Concise Summary of Your Analysis:** This single-cell cluster from human large intestine tissue is unequivocally identified as **Enteric Nervous System Cells**. The marker profile is dominated by genes characteristic of neural crest derivatives, including both glial and neuronal components. Key markers such as **SOX10** (neural crest/glial master regulator), **PLP1** (myelin protein, indicative of Schwann cells/enteric glia), **L1CAM**, **PTPRZ1**, and **GFRA2** strongly point towards an enteric glial cell identity. Concurrently, the presence of numerous neuronal markers like **NRXN1, SYT10, GRIK3, TUBB2B, and CDH2** confirms a significant neuronal component. The co-expression of **SOX2** with SOX10 might also suggest the presence of neural progenitors. The most probable general cell type is **Enteric Nervous System Cells**. The top three most probable sub-cell types are: 1. **Enteric Glial Cells (specifically Schwann cell-like/myelinating glia)** 2. **Enteric Neurons** 3. **Neural Crest Progenitors / Immature Enteric Cells** The most likely specific subtype, given the high expression of **PLP1** in conjunction with **SOX10** and other glial markers, is **Enteric Glial Cells**, possibly representing a specific subtype of glia with myelin-like characteristics or a population closely associated with myelin formation within the ENS. The cluster likely represents a heterogeneous population of ENS cells, with a strong glial signature. FINAL ANNOTATION COMPLETED | Coupling Validator: Validation result: VALIDATION PASSED | Formatting Agent: ```json { ""main_cell_type"": ""Enteric Nervous System Cells"", ""sub_cell_types"": [ ""Enteric Glial Cells"", ""Enteric Neurons"", ""Neural Crest Progenitors / Immature Enteric Cells"" ], ""possible_mixed_cell_types"": [ ""Enteric Glial Cells"", ""Enteric Neurons"" ] } ```"
plasma cell,Plasma Cell,"Mucosal Plasma Cells (IgA-producing Plasma Cells), IgG-producing Plasma Cells, Plasmablasts/Early Plasma Cells","Minor myeloid contamination (due to LILRB4), Minor subset with unique characteristics (due to MYL2)",50,"IGLL5, IGLV6-57, JCHAIN, FAM92B, IGLC3, IGLC2, IGHV3-7, IGKC, TNFRSF17, IGHG1, AC026369.3, IGHV3-23, IGKV4-1, IGKV1-5, IGHA1, IGLV3-1, IGLV2-11, MYL2, MZB1, IGHG3, IGHV3-74, IGHM, ANKRD36BP2, AMPD1, IGKV3-20, IGHA2, DERL3, AC104699.1, LINC02362, AL391056.1, LILRB4, CCL3, BMP6, UBE2QL1, LINC00309, AL133467.1, GPRC5D, FCRL5, DNAAF1, AP002852.1, AC007569.1, CXorf21, RNU1-85P, U62317.4, TXNDC5, LINC02384, CCR10, BFSP2, APOBEC3A, AC106897.1",1,google/gemini-2.5-flash,openrouter,large intestine,human,N/A,"Final Annotation Agent: Okay, I will analyze the provided list of highly expressed markers from a single-cell cluster from human large intestine tissue to identify the cell type. Here's my step-by-step analysis: ### 1. List the Key Functional Markers: This list is overwhelmingly dominated by immunoglobulin-related genes. These genes are directly involved in the production and secretion of antibodies, which is the primary function of plasma cells. * **IGLL5 (Immunoglobulin Lambda-Like Polypeptide 5):** A surrogate light chain component, often highly expressed in plasma cells and plasmablasts, indicating active immunoglobulin production. * **IGLV6-57, IGLC3, IGLC2, IGHV3-7, IGKC, IGHG1, IGHV3-23, IGKV4-1, IGKV1-5, IGHA1, IGLV3-1, IGLV2-11, IGHG3, IGHM, IGKV3-20, IGHA2:** These are various immunoglobulin light chain (IGL, IGK) and heavy chain (IGH) variable (V) and constant (C) region genes. Their high and diverse expression is a hallmark of B-cell lineage cells actively producing antibodies. The presence of different constant regions (IGHG1, IGHG3, IGHA1, IGHA2, IGHM) indicates class-switched antibody production, a characteristic of mature plasma cells. * **JCHAIN (Joining Chain of Immunoglobulin):** A polypeptide that links monomeric immunoglobulin units (IgA or IgM) into dimeric or pentameric forms, essential for their secretion and function, particularly in mucosal tissues. Its high expression strongly points to antibody-secreting cells. * **TNFRSF17 (B-Cell Maturation Antigen - BCMA):** A receptor crucial for plasma cell survival and differentiation, binding to BAFF and APRIL. Its high expression is a definitive marker for plasma cells. * **MZB1 (Marginal Zone B and B1 Cell Specific Protein):** While initially associated with marginal zone B cells, MZB1 is also highly expressed in plasma cells, where it plays a role in immunoglobulin secretion and endoplasmic reticulum stress response. * **DERL3 (Derlin 3):** Involved in ER-associated degradation (ERAD), which is highly active in plasma cells due to their massive protein (antibody) synthesis and secretion. * **GPRC5D (G Protein-Coupled Receptor Class C Group 5 Member D):** While not exclusively functional, it's a known surface marker for plasma cells and is being explored as a therapeutic target in multiple myeloma. * **FCRL5 (Fc Receptor Like 5):** An inhibitory Fc receptor expressed on a subset of B cells and plasma cells, particularly those involved in immune regulation. * **TXNDC5 (Thioredoxin Domain Containing 5):** An ER-resident protein involved in protein folding and disulfide bond formation, highly active in cells with high secretory demands like plasma cells. ### 2. List the Key Cell Type Markers: As established above, the vast majority of the top markers are directly indicative of the B-cell lineage, specifically terminally differentiated antibody-secreting cells. * **B-cell lineage/Plasma cell specific:** IGLL5, IGLV6-57, JCHAIN, IGLC3, IGLC2, IGHV3-7, IGKC, TNFRSF17, IGHG1, IGHV3-23, IGKV4-1, IGKV1-5, IGHA1, IGLV3-1, IGLV2-11, MZB1, IGHG3, IGHM, IGKV3-20, IGHA2, DERL3, GPRC5D, FCRL5, TXNDC5. Other genes: * **FAM92B, AC026369.3, ANKRD36BP2, AMPD1, AC104699.1, LINC02362, AL391056.1, LINC00309, AL133467.1, DNAAF1, AP002852.1, AC007569.1, CXorf21, RNU1-85P, U62317.4, LINC02384, BFSP2, AC106897.1:** Many of these are uncharacterized LINC RNAs, pseudogenes, or genes with less specific roles in the context of highly specialized immune cells. Their presence at lower ranks might indicate general cellular processes or bystander expression. * **MYL2 (Myosin Light Chain 2):** Primarily associated with muscle contraction. Its presence here is unusual for a plasma cell and might indicate contamination, a very minor subset with unique characteristics, or a less specific role in this context (e.g., cell motility, but less likely to be a top marker). However, given the overwhelming immunoglobulin signature, it's likely a minor or non-specific signal in this context. * **LILRB4 (Leukocyte Immunoglobulin Like Receptor B4):** An inhibitory receptor expressed on myeloid cells (monocytes, macrophages, dendritic cells). Its presence here is unexpected for a pure plasma cell cluster and could suggest a minor myeloid contamination or a specific interaction/regulatory role in a subset of plasma cells, though less common. * **CCL3 (Chemokine (C-C motif) Ligand 3):** A chemokine involved in immune cell recruitment. While immune cells produce chemokines, it's not a primary marker for plasma cells themselves, but rather for their interaction with other immune cells. * **BMP6 (Bone Morphogenetic Protein 6):** Involved in bone and cartilage development, but also has roles in immune regulation and inflammation. Its presence in plasma cells is not a canonical marker. * **UBE2QL1 (Ubiquitin Conjugating Enzyme E2 Q1 Like 1):** Involved in ubiquitination. A general cellular process. * **CCR10 (C-C Motif Chemokine Receptor 10):** Expressed on certain T cells, B cells, and dendritic cells, involved in homing to mucosal sites. Its expression on plasma cells, particularly IgA-producing ones in the gut, is plausible for their migration and retention. * **APOBEC3A (APOBEC3 Cytidine Deaminase A):** An antiviral enzyme. While immune cells express antiviral machinery, it's not a defining marker for plasma cells. ### 3. Cross-reference Known Databases: A quick search in scRNA-seq databases (e.g., Human Cell Atlas, PanglaoDB, CellMarker, Azimuth) for ""plasma cell"" or ""B cell"" markers consistently highlights genes like *JCHAIN, IGHG1, IGHA1, IGHM, TNFRSF17 (BCMA), MZB1, IGLL5*. The strong enrichment of these genes in the provided list is highly consistent with plasma cells. The presence of both IgA (IGHA1, IGHA2) and IgG (IGHG1, IGHG3) constant regions, along with IgM (IGHM), suggests a diverse population of class-switched plasma cells, which is common in mucosal tissues like the large intestine. ### 4. Determine the Most Probable General Cell Type: Based on the overwhelming and highly specific expression of immunoglobulin genes (heavy and light chains, variable and constant regions), JCHAIN, TNFRSF17 (BCMA), and MZB1, the most probable general cell type is **Plasma Cell**. These cells are terminally differentiated B lymphocytes specialized in antibody production and secretion. ### 5. Identify the Top 3 Most Probable Sub Cell Types: Given the context of the large intestine and the specific markers, we can refine the plasma cell annotation: 1. **Mucosal Plasma Cells (IgA-producing Plasma Cells):** This is the **most likely** subtype. The large intestine is a major mucosal site where IgA is the predominant antibody isotype, crucial for immune defense at epithelial surfaces. The high expression of **IGHA1** and **IGHA2** (Immunoglobulin Heavy Constant Alpha 1 and 2) strongly supports this. JCHAIN is also critical for IgA dimerization and secretion in mucosal tissues. The presence of CCR10, which mediates homing to mucosal sites, further supports this. 2. **IgG-producing Plasma Cells:** The presence of **IGHG1** and **IGHG3** (Immunoglobulin Heavy Constant Gamma 1 and 3) indicates a significant population of IgG-secreting plasma cells. While IgA is dominant in the gut lumen, IgG-producing plasma cells are also present in the lamina propria and contribute to systemic immunity and local defense. 3. **Plasmablasts/Early Plasma Cells:** While the overall profile points to mature plasma cells, the presence of **IGLL5** (a surrogate light chain component, often higher in plasmablasts) and the general high expression of diverse immunoglobulin genes could also encompass a population of recently differentiated plasmablasts that are rapidly maturing into plasma cells. These cells are still highly proliferative and secretory. **Most Likely Subtype:** **Mucosal (IgA-producing) Plasma Cells.** The strong expression of IGHA1, IGHA2, and JCHAIN in the context of the large intestine makes this the most fitting and specific annotation. The presence of IgG and IgM constant regions indicates a diverse class-switched population, but the IgA signature is particularly prominent and functionally relevant for this tissue. ### 6. Provide a Concise Summary of Your Analysis: This cell cluster from the human large intestine is unequivocally identified as **Plasma Cells**. The annotation is driven by the highly abundant and specific expression of numerous immunoglobulin heavy and light chain genes (e.g., IGHG1, IGHA1, IGHM, IGLC3, IGKC), the immunoglobulin joining chain (JCHAIN), and key plasma cell differentiation and survival markers such as TNFRSF17 (BCMA) and MZB1. The presence of both IgA (IGHA1, IGHA2) and IgG (IGHG1, IGHG3) constant regions indicates a class-switched population. Given the tissue origin (large intestine), the most probable subtype is **Mucosal (IgA-producing) Plasma Cells**, which are critical for local immune defense in the gut, supported by the prominent expression of IgA constant regions and JCHAIN. The cluster likely represents a heterogeneous population of mature plasma cells, with a strong IgA-secreting component, and potentially some IgG-secreting cells. FINAL ANNOTATION COMPLETED | Coupling Validator: Validation result: VALIDATION PASSED | Formatting Agent: ```json { ""main_cell_type"": ""Plasma Cell"", ""sub_cell_types"": [ ""Mucosal Plasma Cells (IgA-producing Plasma Cells)"", ""IgG-producing Plasma Cells"", ""Plasmablasts/Early Plasma Cells"" ], ""possible_mixed_cell_types"": [ ""Minor myeloid contamination (due to LILRB4)"", ""Minor subset with unique characteristics (due to MYL2)"" ] } ```"
transit amplifying cell of large intestine,Proliferating Cells,"Intestinal Stem Cells (ISCs) / Progenitor Cells, Transit-Amplifying (TA) Cells, Activated Immune Cells (e.g., T cells, B cells) or Fibroblasts undergoing proliferation (e.g., in wound healing/inflammation)",,50,"HJURP, UBE2C, CENPA, PBK, AURKB, DLGAP5, CKAP2L, KIF2C, KIF15, BIRC5, SPC25, ASPM, KIF18B, CEP55, DEPDC1, MKI67, CDC45, CDCA5, TOP2A, PCLAF, MND1, RRM2, ZNF695, CCNB2, NUF2, SKA3, SPC24, DTL, PKMYT1, CDCA3, TTK, DIAPH3, PLK1, IQGAP3, CDK1, TK1, POLQ, GTSE1, OIP5, FOXM1, TROAP, SKA1, NEK2, CDC25C, NCAPG, PIMREG, GINS2, RAD51AP1, CDT1, CCNA2",1,google/gemini-2.5-flash,openrouter,large intestine,human,N/A,"Final Annotation Agent: Okay, I will analyze the provided list of highly expressed markers from a single-cell cluster in human large intestine tissue to identify the cell type. Here's my step-by-step analysis: ### Step 1: List the Key Functional Markers The vast majority of the genes in this list are intimately involved in cell cycle progression, DNA replication, and mitosis. This immediately points towards a highly proliferative cell population. * **Cell Cycle Regulation & Mitosis:** * **UBE2C:** Ubiquitin-conjugating enzyme E2 C, crucial for anaphase-promoting complex/cyclosome (APC/C) activation and degradation of mitotic cyclins. * **CENPA:** Centromere protein A, a histone H3 variant essential for centromere identity and kinetochore assembly. * **PBK (PDZ Binding Kinase):** Involved in cell cycle progression, particularly G2/M transition and mitosis. * **AURKB (Aurora Kinase B):** A key mitotic kinase regulating chromosome condensation, spindle assembly, and cytokinesis. * **DLGAP5 (DLG Associated Protein 5):** A spindle pole-associated protein essential for mitotic spindle organization. * **CKAP2L (Cytoskeleton Associated Protein 2 Like):** Involved in microtubule organization and cell division. * **KIF2C (Kinesin Family Member 2C), KIF15 (Kinesin Family Member 15), KIF18B (Kinesin Family Member 18B):** Kinesin motor proteins, critical for various aspects of mitosis including spindle formation, chromosome segregation, and anaphase. * **BIRC5 (Survivin):** A member of the inhibitor of apoptosis protein (IAP) family, essential for cell division and inhibiting apoptosis during mitosis. * **SPC25 (Spindle Pole Body Component 25 Homolog), SPC24 (Spindle Pole Body Component 24 Homolog):** Components of the NDC80 kinetochore complex, crucial for chromosome segregation. * **ASPM (Abnormal Spindle Microtubule Assembly):** Essential for normal spindle function and neurogenesis. * **CEP55 (Centrosomal Protein 55):** Involved in cytokinesis. * **DEPDC1 (DEP Domain Containing 1):** A cell cycle-regulated protein involved in cell proliferation. * **MKI67 (Ki-67):** A classic marker of cell proliferation, expressed during active phases of the cell cycle (G1, S, G2, M). * **CDC45 (Cell Division Cycle 45):** Essential for initiation of DNA replication and progression through S phase. * **CDCA5 (Cell Division Cycle Associated 5):** Involved in sister chromatid cohesion and chromosome segregation. * **TOP2A (DNA Topoisomerase II Alpha):** Essential for DNA replication, transcription, and chromosome segregation. * **PCLAF (PCNA-associated factor):** Involved in DNA replication and repair. * **MND1 (Meiotic Nuclear Division 1 Homolog):** Involved in homologous recombination and DNA repair, particularly during meiosis, but also has roles in mitotic DNA repair. * **RRM2 (Ribonucleotide Reductase M2):** Catalyzes the rate-limiting step in dNTP synthesis, essential for DNA replication. * **CCNB2 (Cyclin B2):** A mitotic cyclin, forms a complex with CDK1 to promote entry into mitosis. * **NUF2 (NUF2 Component Of NDC80 Kinetochore Complex):** Part of the NDC80 kinetochore complex, essential for chromosome segregation. * **SKA3 (Spindle And Kinetochore Associated Complex Subunit 3), SKA1 (Spindle And Kinetochore Associated Complex Subunit 1):** Components of the SKA complex, essential for stable kinetochore-microtubule attachments. * **DTL (Denticleless E3 Ubiquitin Protein Ligase Homolog):** Involved in DNA damage response and cell cycle control. * **PKMYT1 (Protein Kinase, Myelin Transcription Factor 1):** A kinase that inhibits CDK1, involved in G2/M checkpoint. * **CDCA3 (Cell Division Cycle Associated 3):** Involved in cell cycle progression, particularly mitosis. * **TTK (Dual Specificity Kinase TTK):** A mitotic checkpoint kinase, essential for proper chromosome segregation. * **DIAPH3 (Diaphanous Related Formin 3):** Involved in actin cytoskeleton organization and cytokinesis. * **PLK1 (Polo-Like Kinase 1):** A master regulator of mitosis, involved in centrosome maturation, spindle assembly, and cytokinesis. * **IQGAP3 (IQ Motif And GTPase Activating Protein 3):** Involved in cell proliferation and migration. * **CDK1 (Cyclin Dependent Kinase 1):** The master regulator of mitotic entry and progression. * **TK1 (Thymidine Kinase 1):** Involved in DNA synthesis, a marker of cell proliferation. * **POLQ (DNA Polymerase Theta):** Involved in DNA repair, particularly alternative end-joining. * **GTSE1 (G2 And S-Phase Expressed 1):** Involved in cell cycle regulation and DNA damage response. * **OIP5 (OPA-Interacting Protein 5):** Involved in cell cycle progression and chromosome segregation. * **FOXM1 (Forkhead Box M1):** A transcription factor that regulates the expression of many genes involved in cell cycle progression, particularly G2/M. * **TROAP (Trophinin Associated Protein):** Involved in cell proliferation and cell adhesion. * **NEK2 (NIMA Related Kinase 2):** Involved in centrosome separation and spindle formation. * **CDC25C (Cell Division Cycle 25C):** A phosphatase that activates CDK1, promoting entry into mitosis. * **NCAPG (Non-SMC Condensin I Complex Subunit G):** A component of the condensin complex, essential for chromosome condensation. * **PIMREG (PIM Kinase Interacting Cell Cycle Regulator):** Involved in cell cycle regulation. * **GINS2 (GINS Complex Subunit 2):** A component of the GINS complex, essential for DNA replication initiation and elongation. * **RAD51AP1 (RAD51 Associated Protein 1):** Involved in homologous recombination and DNA repair. * **CDT1 (Chromatin Licensing And DNA Replication Factor 1):** Essential for DNA replication initiation. * **CCNA2 (Cyclin A2):** A cyclin involved in both S phase and M phase progression. * **Other:** * **HJURP (Holliday Junction Recognition Protein):** Involved in CENPA deposition at centromeres, crucial for centromere maintenance. * **ZNF695 (Zinc Finger Protein 695):** Less directly linked to cell cycle, but some zinc finger proteins are involved in transcriptional regulation of cell cycle genes. ### Step 2: List the Key Cell Type Markers Based on the provided list, there are no specific markers for differentiated cell types of the large intestine (e.g., enterocytes, goblet cells, Paneth cells, enteroendocrine cells, immune cells, stromal cells). Instead, the markers are overwhelmingly indicative of a proliferative state, common across various tissues for cells undergoing division. ### Step 3: Cross-reference Known Databases Cross-referencing these markers with scRNA-seq databases (e.g., Human Cell Atlas, PanglaoDB, CellMarker) and literature consistently identifies them as markers for: * **Proliferating cells:** This is the most consistent and strong signal. * **Stem cells/Progenitor cells:** These populations are inherently proliferative. * **Cancer cells:** Many of these genes are upregulated in various cancers due to uncontrolled proliferation. In the context of the large intestine, a highly proliferative tissue, these markers strongly point to cells within the crypts that are actively dividing. ### Step 4: Determine the Most Probable General Cell Type Given the overwhelming expression of genes involved in DNA replication, cell cycle progression, and mitosis (e.g., *MKI67, UBE2C, CENPA, AURKB, BIRC5, TOP2A, RRM2, CDK1, PLK1, FOXM1, TK1, CDC45, CCNB2, CCNA2*), the most probable general cell type is **Proliferating Cells**. ### Step 5: Identify the Top 3 Most Probable Sub Cell Types Within the large intestine, proliferating cells are primarily found in the crypts. 1. **Most Likely: Intestinal Stem Cells (ISCs) / Progenitor Cells:** These cells reside at the base of the crypts and are responsible for continuously replenishing the intestinal epithelium. They are highly proliferative and express many of the cell cycle genes observed. While specific ISC markers (e.g., *LGR5, OLFM4, ASCL2*) are not explicitly in the provided list, the strong proliferative signature is characteristic of these populations. The high expression of *MKI67* and other mitotic genes is a hallmark of these rapidly dividing cells. 2. **Second Most Likely: Transit-Amplifying (TA) Cells:** These are daughter cells of ISCs that undergo several rounds of rapid division as they migrate up the crypt before differentiating. They are also highly proliferative and would express a similar set of cell cycle markers, often even more intensely than ISCs as they are in a state of rapid expansion. 3. **Third Most Likely: Activated Immune Cells (e.g., T cells, B cells) or Fibroblasts undergoing proliferation (e.g., in wound healing/inflammation):** While less likely to be the primary population given the sheer number and specificity of mitotic markers, immune cells or fibroblasts can proliferate in response to activation or injury. However, their proliferative signature would typically be accompanied by immune-specific or stromal-specific markers, which are absent here. The consistent and comprehensive list of mitotic genes strongly points to an epithelial lineage's inherent proliferative capacity. **Most Likely Subtype:** Based on the comprehensive and highly ranked list of cell cycle and mitotic genes, the most likely subtype is **Intestinal Stem Cells (ISCs) and/or Transit-Amplifying (TA) Cells** within the large intestine crypts. These two populations are functionally linked and both exhibit intense proliferative activity. Without specific ISC markers like *LGR5* or *OLFM4*, it's difficult to definitively separate them, but the overall signature is perfectly consistent with these rapidly dividing epithelial precursors. ### Step 6: Provide a Concise Summary of Your Analysis The single-cell cluster from human large intestine tissue exhibits a robust and comprehensive expression profile of genes critically involved in DNA replication, cell cycle progression, and mitosis (e.g., *MKI67, UBE2C, AURKB, BIRC5, TOP2A, CDK1, PLK1, FOXM1*). This overwhelming signature unequivocally identifies the cluster as a population of **highly proliferating cells**. In the context of the large intestine, this points to the epithelial lineage responsible for tissue renewal. Therefore, the most probable general cell type is **Proliferating Cells**. The top three most probable sub cell types are **Intestinal Stem Cells (ISCs) / Progenitor Cells**, **Transit-Amplifying (TA) Cells**, and less likely, activated immune or stromal cells. Given the extensive list of mitotic machinery components, the most likely specific subtype is a population encompassing both **Intestinal Stem Cells and Transit-Amplifying Cells** within the intestinal crypts, which are continuously dividing to maintain the epithelial lining. FINAL ANNOTATION COMPLETED. | Coupling Validator: Validation result: VALIDATION PASSED | Formatting Agent: ```json { ""main_cell_type"": ""Proliferating Cells"", ""sub_cell_types"": [ ""Intestinal Stem Cells (ISCs) / Progenitor Cells"", ""Transit-Amplifying (TA) Cells"", ""Activated Immune Cells (e.g., T cells, B cells) or Fibroblasts undergoing proliferation (e.g., in wound healing/inflammation)"" ], ""possible_mixed_cell_types"": [] } ```"
